August 20, 2015

Treating Essential Tremor

Common disorder raises uncommon issues for physicians


Chances are good that you’ll encounter essential tremor (ET) in your primary care practice. It’s the most common movement disorder, affecting all age ranges and as many as 6 to 9 percent of people 60 and older according to prevalence studies.


Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

But due to embarrassment, fear or normalization, your patients may not volunteer that they’re having problems. That means you’ll have to rely more on observational and interview skills to uncover what’s going on and begin the diagnostic and treatment process, says Cleveland Clinic neurologist Michal Gostkowski, DO. Some advice on how to proceed:

Initial signs

ET involuntary movements most often involve the hands and occur during action, in contrast to Parkinson disease (PD) tremors, which occur at rest. ET patients may try to mask or hide their shaking, so Dr. Gostkowski watches their hands when they’re distracted and listens to vocal tremors, another distinctive ET symptom. He also asks if their activities have changed. ET patients may stop socializing or discontinue hobbies that are affected by their tremors. Those restrictions, in turn, may trigger depression, another indicator to watch for. Also, since alcohol can temporarily dampen ET tremors, sufferers may be vulnerable to alcohol overuse or addiction.

Other diagnostic aids

Though ET has its own complications, your patient’s biggest early concern may be that his or her tremors result from PD. A neurologist can make the definitive diagnosis, but for reassurance’s sake, some simple tests in your office — handwriting and water-pouring ability can help differentiate ET from PD. ET patients’ handwriting is large and scratchy-looking, while PD patients’ rigidity results in smaller and smaller printing (a condition called micrographia). ET patients also have trouble pouring water from one cup to another, a task that PD patients execute without spills because their tremors occur at rest.


Patient questions

Your patients likely will ask what caused their ET and what course their disease will take. Though ET clearly has a strong genetic component, no ET-linked genes have been identified so far, and it is likely that some as-yet unknown environmental cofactors are involved. Tremors tend to become more severe as patients age, with some association between age of ET onset and how quickly ET progresses. Older-onset patients have a faster rate of progression.

Medical treatment

Unfortunately, medications are only modestly effective at reducing ET tremors. The beta-blocker propranolol and the anti-seizure drug primidone are the most studied and seemingly the more beneficial, but each lessens tremor in about half of ET patients. Other ET medications include benzodiazepines and anticholinergics, which should be used cautiously in older patients.


Deep brain stimulation (DBS) of the thalamus has shown good results in ET. “It’s a very viable option,” Dr. Gostkowski says. “We expect 70 percent to 80 percent improvement in the tremor in about 90 percent of patients,” with minimal side effects. ET patients and their physicians should consider DBS when tremors begin to impair daily living activities.


Related Articles

photo of woman looking anxious on a couch
February 22, 2024
Success of POTS Treatment Reduced by Concurrent Anxiety

Guidance from an expert on distinguishing — and co-managing — the disorders

DNA gel showing genetic sequencing
February 20, 2024
Large GWAS Meta-Analysis Identifies Multiple New Genetic Risk Factors for Epilepsy

Characterizing genetic architecture of clinical subtypes may accelerate targeted therapy

February 19, 2024
Central Sensitization Syndromes in Pediatric Patients (Podcast)

How functional restoration can help children with these conditions marked by unexplained pain with stigmatized symptoms

pathology image of a Lewy body inclusion
February 15, 2024
Lewy Body Pathology Linked to Cerebral Amyloid Angiopathy in Alzheimer’s Disease Patients

Recognizing this association aids risk assessment before starting novel immunotherapies

image of astrocyte cell stained with antibodies to GFAP
February 14, 2024
Longitudinal Study Links Biomarker Level With Repetitive Head Injury-Associated Neurodegeneration

GFAP elevation may signal increased risk of progressive regional atrophy, cognitive decline

February 9, 2024
Thrombolytics Compared in Large Vessel Occlusion Patients Undergoing Mechanical Thrombectomy

Higher complete reperfusion rate seen with tenecteplase vs. alteplase in single-center study of stroke with LVO

Cleveland Clinic Mobile Stroke Unit
February 8, 2024
Mobile Stroke Treatment Units Provide Faster Treatment for Acute Intracerebral Hemorrhage

Times to target blood pressure, CT and medication administration shorter than with EMS transport

February 7, 2024
Analysis Documents Lingering Racial, Ethnic Gaps Despite Gains in National Stroke Quality Initiative

Target: Stroke yields more frequent and faster thrombolysis, but disparities remain for non-white population